EPO Patent Application EP4709707A1: NMDA Receptor Antagonists
Summary
The European Patent Office has published patent application EP4709707A1 concerning antagonists of N-methyl-D-aspartate receptors and their use. The application was filed by Fakultní Nemocnice Hradec Králové and Ustav Experimentalni Mediciny Akademie Ved Cr, v.v.i. and lists several inventors.
What changed
This document is a publication of a European patent application (EP4709707A1) related to antagonists of N-methyl-D-aspartate receptors and their therapeutic uses. The application was filed by Fakultní Nemocnice Hradec Králové and Ustav Experimentalni Mediciny Akademie Ved Cr, v.v.i., with a publication date of March 18, 2026. It includes various IPC classifications related to chemical compounds and their medical applications, specifically targeting neurological conditions.
This patent filing does not impose any new regulatory obligations on companies. It represents an intellectual property filing that may affect future research and development in the pharmaceutical sector, particularly concerning treatments for neurological disorders. Compliance officers should note this as a development in the IP landscape for relevant therapeutic areas.
Source document (simplified)
ANTAGONISTS OF N-METHYL-D-ASPARTATE RECEPTORS AND USE THEREOF
Publication EP4709707A1 Kind: A1 Mar 18, 2026
Applicants
Fakultní Nemocnice Hradec Králové, Ustav Experimentalni Mediciny Akademie
Ved Cr, v.v.i.
Inventors
KONECNY, Jan, SVOBODOVA, Barbora, KORABECNY, Jan, SOUKUP, Ondrej, HORAK, Martin, MISIACHNA, Anna
IPC Classifications
C07C 211/42 20060101AFI20241115BHEP C07C 215/08 20060101ALI20241115BHEP C07C 15/08 20060101ALI20241115BHEP C07C 217/08 20060101ALI20241115BHEP C07D 295/033 20060101ALI20241115BHEP A61P 25/16 20060101ALI20241115BHEP A61P 25/28 20060101ALI20241115BHEP A61K 31/135 20060101ALI20241115BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Therapeutics (A61P) publishes new changes.